Overview

Gender

female

Investor Type

Investment Partner

Ms. Seltzer serves as a Partner of Aisling Capital. Previously, Ms. Seltzer was at Schering-Plough, where she held roles in business development, marketing and sales, most recently serving as the US Schering-Plough Brand Lead for Zetia. While in business development, Ms. Seltzer was involved in the structuring and negotiation of several deals with an aggregate value in the billions, ranging from in-licensing deals to broad development and commercialization alliances.

Prior to Schering-Plough, Ms. Seltzer was the Director of Business Development for Akceli, a biotechnology company developing cell-based microarrays. Ms. Seltzer began her career as a management consultant for McKinsey & Company.

Ms. Seltzer serves as a director of Miramar Labs, acts as the Aisling representative for its investment in Precision Dermatology and serves as a board observer for Durata Therapeutics and Agile Therapeutics. She was previously a board observer for Zeltiq Aesthetics (NASDAQ: ZLTQ).